Home > M&A deals 2017 > Capital Southwest Corp. and New Harbor Capital acquire LGM Pharma
Buyout (LBO, MBO, MBI) · Life Science · November 2017

Capital Southwest Corp. and New Harbor Capital acquire LGM Pharma

On November 20, 2017, Capital Southwest Corp. and New Harbor Capital acquired LGM Pharma, a life science company in Tennessee, United States.

Deal at a glance

AnnouncedNovember 20, 2017 TypeBuyout (LBO, MBO, MBI) TargetLGM Pharma Buyers Capital Southwest Corp.
New Harbor Capital SectorLife Science LocationTennessee, United States ValueNot disclosed

Target company

LGM Pharma
Tennessee, United States
Life Sciencesector
-founded
Activestatus
View the company profile →

Buyers (2)

Capital Southwest Corp. Lead
Private equity firm · 47 deals on record
New Harbor Capital Co-investor
Private equity firm · 12 deals on record
  • 1st transaction for the lead buyer in life science
  • 19th transaction in United States
47deals, all time
2in this sector
2020latest

Members only

Contact details at the buyers and sellers
The full deal history of every party
Co-investors and the other advisors on this deal
Deal value and revenue or EBITDA multiples

Related deals

Orbus Therapeutics, Inc.Same sector and country · Oct 2026
ArtesRx LLCSame sector and country · Aug 2026
Firefly Bio, Inc.Same sector and country · Jul 2026

Questions about this deal

Who acquired LGM Pharma?Capital Southwest Corp. and New Harbor Capital acquired LGM Pharma on November 20, 2017.

What type of deal was it?It was a buyout (lbo, mbo, mbi) in the life science sector in 2017.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.
Try it free
Data updated daily on AcquityData (Acquity Data).